graphic
abstract
highlight
promot
hcv
replic
independ
protect
hcv
rna
stimul
hcv
rna
synthesi
prior
promot
viral
protein
synthesi
stimul
rna
synthesi
requir
activ
protein
translat
displac
rebal
rna
engag
rna
versu
protein
synthesi
summari
liverspecif
microrna
stabil
hepat
c
viru
hcv
rna
genom
recruit
host
argonaut
end
prevent
decay
mediat
exonucleas
howev
hcv
replic
requir
cell
indic
addit
function
show
enhanc
hcv
rna
level
alter
fraction
hcv
genom
avail
rna
synthesi
exogen
increas
viral
rna
protein
level
cell
enhanc
rna
synthesi
occur
heighten
protein
synthesi
inhibit
protein
translat
puromycin
block
increas
rna
synthesi
independ
enhanc
rna
synthesi
releas
ribosom
viral
genom
addit
reduc
fraction
viral
genom
engag
protein
translat
deplet
bind
hcv
rna
competit
promot
translat
elimin
stimul
rna
synthesi
thu
displac
reduc
hcv
genom
engag
translat
increas
fraction
avail
rna
synthesi
brief
import
host
factor
hcv
act
part
protect
genom
decay
masaki
et
al
show
also
directli
stimul
viral
rna
synthesi
compet
bind
rna
increas
fraction
viral
rna
engag
replic
versu
translat
hepat
c
viru
hcv
import
human
pathogen
infect
mani
million
person
worldwid
caus
endstag
liver
diseas
hepatocellular
carcinoma
thoma
classifi
within
famili
flavivirida
possess
uncap
positivesens
singlestrand
rna
genom
structur
untransl
region
utr
flank
larg
open
read
frame
encod
polyprotein
process
ten
viral
protein
scheel
rice
utr
contain
intern
ribosom
entri
site
ire
mediat
capindepend
initi
viral
protein
synthesi
extrem
end
rna
signal
essenti
genom
replic
frieb
et
al
honda
et
al
utr
serv
platform
recruit
cellular
factor
essenti
viral
translat
andor
rna
replic
includ
among
other
poli
rc
bind
protein
eukaryot
initi
factor
microrna
fukushi
et
al
jopl
et
al
kieft
et
al
pestova
et
al
wang
et
al
highli
express
liverspecif
small
rna
account
larg
fraction
mirna
hepatocyt
chang
et
al
regul
express
numer
liverspecif
gene
posttranscript
bind
utr
cellular
mrna
chang
et
al
lanford
et
al
contrast
typic
mirna
action
bind
two
conserv
site
near
end
hcv
utr
stimul
replic
viru
jangra
et
al
jopl
et
al
jopl
et
al
mutat
introduc
site
disrupt
bind
sever
impair
replic
jangra
et
al
jopl
et
al
norman
sarnow
howev
viru
mutant
rescu
transfect
modifi
oligonucleotid
contain
complementari
mutat
restor
bind
utr
indic
promot
hcv
replic
directli
indirectli
modul
host
gene
express
silenc
administr
complementari
lock
nucleic
acid
lna
oligom
shown
therapeut
promis
preclin
clinic
studi
janssen
et
al
lanford
et
al
highlight
import
viru
life
cycl
although
well
establish
understand
promot
hcv
replic
remain
elus
earli
studi
suggest
might
act
part
stimul
iresdirect
translat
henk
et
al
later
work
support
view
jangra
et
al
robert
et
al
zhang
et
al
recent
data
suggest
increas
viral
protein
express
may
result
unusu
stabil
effect
hcv
genom
shimakami
et
al
recruit
argonaut
protein
end
viral
rna
conrad
et
al
shimakami
et
al
protect
genom
decay
mediat
cytoplasm
exonucleas
li
et
al
thu
compet
effect
stabil
rate
decay
hcv
rna
infect
cell
deplet
enhanc
viral
rna
abund
product
infecti
viru
cell
cultur
li
et
al
howev
effect
stabil
hcv
rna
cell
due
absenc
exonucleas
activ
supplement
cell
exogen
continu
boost
hcv
replic
li
et
al
furthermor
deplet
rescu
replic
viral
mutant
defect
bind
li
et
al
result
indic
addit
key
function
hcv
replic
cycl
beyond
abil
physic
stabil
genom
li
et
al
consist
mutant
protect
rna
decay
yet
fail
promot
viru
replic
mortim
doudna
demonstr
direct
involv
viral
rna
synthesi
show
augment
endogen
abund
stimul
viral
rna
synthesi
condit
deplet
effect
viral
rna
stabil
find
translat
replic
viral
rna
tightli
coupl
process
increas
rna
synthesi
tempor
preced
increas
viral
protein
synthesi
surprisingli
howev
stimul
viral
rna
synthesi
absenc
activ
protein
translat
follow
rnaimedi
deplet
result
indic
primari
function
enhanc
hcv
rna
synthesi
suggest
mechan
alter
balanc
viral
genom
engag
genom
synthesi
versu
protein
translat
although
posit
influenc
hcv
genom
amplif
well
known
remain
unclear
whether
primari
effect
viral
protein
viral
rna
synthesi
two
critic
step
viral
life
cycl
thu
compar
kinet
increas
abund
viral
rna
viral
protein
hcvinfect
cell
effort
determin
whether
one
preced
thu
might
repres
primari
effect
supplement
endogen
abund
virusinfect
cell
transfect
synthet
duplex
control
brainspecif
mirna
see
experiment
procedur
stabil
genom
rna
protect
decay
li
et
al
examin
kinet
hcv
rna
protein
accumul
without
prior
sirnamedi
deplet
figur
predominantli
nuclear
exonucleas
also
suggest
mediat
hcv
rna
decay
sedano
sarnow
howev
found
deplet
effect
decay
rna
wherea
deplet
significantli
slow
figur
moreov
confirm
supplement
minim
nonsignific
effect
rna
decay
cell
figur
li
et
al
nonetheless
supplement
mediat
signific
increas
viral
rna
abund
protein
express
cell
well
cell
transfect
nontarget
sirna
sictrl
li
et
al
figur
expect
li
et
al
increas
greater
sictrlthan
cell
figur
multipl
experi
increas
viral
rna
abund
occur
similar
kinet
signific
within
hr
follow
transfect
figur
result
demonstr
close
coupl
increas
viral
rna
synthesi
protein
express
reveal
primari
target
given
tight
coupl
viral
rna
protein
synthesi
develop
method
measur
process
directli
metabol
label
figur
confirm
deplet
figur
cell
label
either
uridin
eu
methioninecystein
follow
transfect
control
nascent
viral
rna
measur
qrtpcr
follow
pulldown
biotinconjug
eulabel
rna
see
experiment
procedur
use
yfp
viru
experi
express
intern
yellow
fluoresc
protein
yfp
fusion
allow
measur
nascent
protein
synthesi
immunoprecipit
label
antiyfp
antibodi
follow
sdspage
phosphorimag
analysi
figur
remark
observ
reproduc
increas
nascent
viral
rna
synthesi
within
hr
cell
transfect
versu
wherea
measur
increas
fact
slight
signific
decreas
synthesi
period
figur
p
twosid
mannwhitney
test
increas
synthesi
observ
later
time
point
like
increas
viral
rna
avail
translat
sinc
replic
rna
approxim
hr
cell
figur
increas
viral
rna
synthesi
hr
explain
enhanc
rna
stabil
moreov
appear
protect
newli
synthes
rna
degrad
effect
observ
cell
figur
collect
data
provid
strong
evid
directli
promot
hcv
rna
synthesi
confirm
close
coupl
viral
rna
protein
synthesi
recruit
end
hcv
rna
requir
stabil
hcv
rna
amplif
viral
rna
abund
conrad
et
al
shimakami
et
al
determin
whether
also
requir
stimul
viral
rna
synthesi
transfect
cell
sirna
prior
supplement
figur
consist
earlier
find
shimakami
et
al
viral
rna
synthesi
significantli
reduc
cell
compar
cell
transfect
control
sirna
figur
p
importantli
contrast
result
shown
figur
increas
viral
rna
synthesi
first
hour
transfect
figur
thu
stimul
rna
synthesi
fashion
sequestr
viral
rna
synthesi
next
consid
whether
sequest
transfect
complementari
lna
antagomir
would
effect
opposit
supplement
reduc
hcv
rna
synthesi
shortterm
experi
given
regul
rna
synthesi
requir
figur
first
compar
kinet
supplement
sequestr
modul
load
mirna
pulldown
follow
qrtpcr
quantit
coimmunoprecipit
reveal
transfect
result
increas
within
hr
figur
contrast
transfect
reduc
abund
bound
hr
hr
figur
keep
slow
kinet
sequestr
reduc
neither
viral
rna
synthesi
reduc
hr
transfect
lna
figur
howev
significantli
reduc
hr
posttransfect
p
p
hcv
rna
compar
cell
transfect
antirandom
control
consist
exert
primari
effect
viral
rna
synthesi
reduct
nascent
rna
significantli
greater
nascent
sem
antirandom
control
rna
versu
p
directli
assess
abund
influenc
hcv
protein
translat
absenc
ongo
viral
rna
synthesi
treat
stabli
infect
cell
potent
inhibitor
rnadepend
rna
polymeras
figur
achiev
highlevel
deplet
figur
cell
treat
sofosbuvir
sof
hr
transfect
duplex
hcv
rna
synthesi
quantifi
describ
hcv
rna
synthesi
reduc
background
level
inhibitor
figur
left
support
specif
assay
total
hcv
rna
reduc
still
abund
cell
experiment
design
virusinfect
cell
transfect
scrambl
control
sictrl
sirna
day
later
retransfect
duplex
mirna
hr
harvest
time
indic
assay
hcv
rna
protein
b
immunoblot
core
protein
hr
bactin
load
control
c
hcv
rna
abund
cell
transfect
sictrl
supplement
rna
quantifi
qrtpcr
rel
bactin
mrna
immunoblot
protein
cell
transfect
top
panel
sictrl
bottom
panel
follow
supplement
e
express
quantifi
base
infrar
fluoresc
intens
immunoblot
shown
rel
bactin
express
result
shown
c
e
repres
mean
fold
chang
sem
hr
triplic
cultur
repres
multipl
independ
experi
p
versu
twoway
anova
correct
multipl
comparison
increas
rna
protein
greater
sictrltransfect
cell
cell
hr
p
see
also
figur
copiesmg
total
rna
end
label
period
figur
right
differ
abund
cell
supplement
versu
transfect
confirm
stabil
effect
hcv
rna
deplet
cell
li
et
al
amount
newli
synthes
label
protein
also
reduc
polymeras
inhibitor
due
reduct
rna
templat
avail
translat
figur
importantli
howev
supplement
caus
margin
nonsignific
increas
synthesi
softreat
cell
figur
data
agreement
primari
effect
hcv
rna
synthesi
viral
protein
translat
translat
incom
positivestrand
rna
viru
genom
necessari
establish
replic
complex
initi
viral
rna
synthesi
newli
infect
cell
prior
studi
indic
continu
protein
translat
requir
ongo
hcv
flavivir
rna
synthesi
shi
et
al
westaway
et
al
suggest
essenti
replicas
compon
either
recycl
new
round
viral
rna
synthesi
present
excess
abund
determin
whether
would
induc
increas
rna
synthesi
absenc
ongo
translat
treat
infect
cell
puromycin
cycloheximid
chx
figur
cell
lysat
immunoprecipit
rabbit
antigfp
antibodi
antigfp
lane
isotyp
control
ig
lane
immunoprecipit
separ
sdspage
label
protein
visual
phosphorimag
analysi
label
period
hr
indic
near
top
increas
hcv
rna
synthesi
follow
supplement
hcv
rna
precipit
quantifi
qrtpcr
quantifi
phosphorimag
analysi
sdspage
gel
result
hcv
rna
shown
bar
repres
mean
fold
increas
sem
cell
supplement
rel
cell
supplement
control
label
period
rang
hr
posttransfect
individu
result
replic
independ
experi
plot
empti
hcv
rna
full
symbol
p
twosid
mannwhitney
test
e
immunoblot
show
abund
cell
transfect
hr
previous
sictrl
f
impact
supplement
nascent
hcv
rna
cell
deplet
label
period
hr
follow
transfect
mirinhibitor
caus
complet
nearcomplet
inhibit
viral
cellular
protein
synthesi
without
notic
effect
total
cellular
protein
abund
hr
cours
experi
figur
surprisingli
shortterm
treatment
hr
puromycin
increas
nascent
viral
rna
synthesi
much
supplement
absenc
puromycin
figur
contrast
increas
nascent
viral
rna
synthesi
treatment
chx
figur
differ
like
due
puromycininduc
dissoci
translat
ribosom
viral
rna
would
lead
increas
avail
viral
rna
templat
rna
synthesi
observ
vitro
polioviru
barton
et
al
contrast
chx
freez
ribosom
prevent
clearanc
rna
even
surpris
howev
supplement
effect
nascent
viral
rna
synthesi
cell
treat
either
puromycin
chx
figur
lack
stimul
rna
synthesi
relat
insuffici
abund
minim
reduc
hr
translat
shutoff
figur
moreov
although
reduc
untreat
cell
supplement
substanti
increas
quantiti
coimmunoprecipit
lysat
puromycintr
cell
figur
lengthier
shutdown
protein
synthesi
hr
exceed
estim
halfliv
nonstructur
hcv
protein
pietschmann
et
al
significantli
decreas
viral
rna
synthesi
cell
similarli
elimin
enhanc
nascent
viral
rna
synthesi
figur
collect
result
confirm
earlier
report
continu
protein
translat
requir
hcv
rna
synthesi
long
suffici
abund
requisit
nonstructur
protein
shi
et
al
westaway
et
al
contrast
activ
protein
translat
requir
stimul
hcv
rna
synthesi
sinc
puromycin
treatment
supplement
caus
similar
nonaddit
increas
hcv
rna
synthesi
figur
consid
possibl
common
underli
mechan
puromycin
increas
polioviru
rna
synthesi
cellfre
replic
reaction
clear
ribosom
viral
rna
therebi
provid
templat
rna
synthesi
barton
et
al
partial
inhibit
hcv
translat
initi
could
similar
impact
viral
rna
synthesi
assess
possibl
analyz
distribut
hcv
rna
ratezon
gradient
load
polysom
isol
infect
cell
hr
transfect
control
figur
anticip
induc
decreas
proport
hcv
rna
associ
polysom
engag
translat
figur
fraction
increas
less
translat
activ
rna
cosedi
ribosom
fraction
figur
chang
less
observ
puromycin
figur
reproduc
statist
signific
p
contrast
chang
evid
bactin
mrna
distribut
substanti
smaller
chang
occur
distribut
chlorid
intracellular
channel
cation
amino
acid
transport
mrna
within
hour
transfect
natur
target
mirna
figur
conclud
result
induc
immedi
rebalanc
proport
viral
rna
engag
translat
versu
templat
new
viral
rna
result
shown
mean
percent
sem
compar
cell
transfect
antirandom
n
label
period
hr
posttransfect
c
p
twosid
mannwhitney
test
synthesi
hr
increas
newli
synthes
rna
result
net
increas
viral
protein
synthesi
figur
although
redistribut
hcv
rna
persist
figur
addit
sever
cellular
protein
includ
heterogen
nuclear
ribonuclear
protein
hnrnp
hnrnp
l
bind
end
hcv
genom
facilit
replic
fukushi
et
al
li
et
al
wang
et
al
particular
interest
regul
iresiniti
translat
polioviru
anoth
positivestrand
rna
viru
facilit
circular
translat
hcv
genom
perera
et
al
wang
et
al
recent
studi
laboratori
also
show
compet
bind
synthet
rna
repres
nt
hcv
li
et
al
figur
similar
pulldown
experi
found
twobas
chang
nt
within
bind
site
ablat
hnrnp
l
bind
figur
confirm
major
bind
site
overlap
one
two
function
bind
site
suggest
turn
might
skew
engag
viral
rna
molecul
away
translat
toward
rna
synthesi
compet
displac
case
reason
supplement
would
littl
posit
effect
hcv
rna
synthesi
cell
deplet
test
hypothesi
deplet
stabli
infect
cell
two
success
transfect
sirna
figur
result
modest
reduct
hcv
rna
abund
hr
second
sirna
transfect
sictrltransfect
cell
p
p
respect
figur
transfect
cell
assess
nascent
hcv
rna
synthesi
use
method
describ
cell
supplement
control
mirna
prior
deplet
reduc
synthesi
control
cell
figur
p
contrast
reduct
viral
rna
synthesi
figur
suggest
deplet
either
increas
effici
rna
synthesi
proport
hcv
rna
engag
viral
rna
synthesi
furthermor
anticip
supplement
stimul
either
viral
protein
viral
rna
synthesi
cell
figur
conclud
promot
new
viral
rna
synthesi
least
part
displac
viral
rna
decreas
fraction
viral
rna
engag
translat
proport
increas
fraction
avail
templat
viral
rna
synthesi
although
found
import
host
factor
hcv
almost
decad
ago
jopl
et
al
understand
role
viral
life
cycl
remain
elus
previou
work
indic
bind
two
site
near
end
viral
genom
stabil
rna
protect
within
infect
cell
decay
li
et
al
shimakami
et
al
although
recent
report
suggest
predominantli
nuclear
exonucleas
mediat
hcv
rna
decay
sedano
sarnow
unabl
demonstr
experiment
figur
importantli
confirm
longer
influenc
stabil
rna
cell
figur
moreov
supplement
increas
abund
previous
synthes
nascent
rna
detect
control
cell
cell
figur
collect
data
provid
strong
justif
use
cell
experi
describ
supplement
infect
cell
exogen
enhanc
express
hcv
protein
jangra
et
al
extent
result
direct
effect
viral
ire
secondari
stabil
genom
increas
genom
synthesi
unresolv
conrad
et
al
henk
et
al
robert
et
al
shimakami
et
al
develop
method
allow
direct
comparison
influenc
viral
rna
synthesi
versu
synthesi
essenti
viral
nonstructur
protein
abl
show
transfect
duplex
induc
signific
increas
viral
rna
synthesi
cell
prior
increas
viral
protein
synthesi
figur
data
provid
strong
evid
act
directli
promot
hcv
rna
synthesi
lead
secondari
increas
viral
protein
synthesi
subsequ
expans
viral
replic
complex
kinet
analys
increas
viral
rna
protein
abund
follow
transfect
cell
indic
tight
coupl
hcv
translat
rna
replic
figur
positivestrand
rna
virus
continu
protein
translat
requir
ongo
synthesi
viral
rna
exampl
polioviru
rna
synthesi
depend
translat
activ
viral
rna
novak
kirkegaard
continu
protein
synthesi
requir
rna
synthesi
coronaviru
mous
hepat
viru
hagemeij
et
al
shi
et
al
previou
data
suggest
case
flavivirus
includ
hcv
shi
et
al
westaway
et
al
confirm
figur
graph
left
top
bottom
repres
distribut
hcv
rna
bactin
mrna
across
gradient
fraction
rna
result
mean
sem
percent
total
rna
gradient
two
independ
experi
cell
harvest
hr
mirna
transfect
right
ratio
cumul
percent
rna
fraction
divid
fraction
polysom
gradient
lysat
collect
hr
supplement
result
shown
repres
mean
sem
three
gradient
three
independ
experi
b
polysom
analysi
lysat
cell
treat
hr
puromycin
pur
mgml
mirna
supplement
releas
rna
polysom
partial
lysat
expos
highsalt
condit
prior
centrifug
intent
reflect
condit
puromycintr
cell
shown
figur
right
shown
ratio
percent
hcv
rna
actin
mrna
fraction
divid
percent
fraction
polysom
gradient
shown
left
c
similar
polysom
analys
mrna
lysat
collect
hr
transfect
panel
p
p
twosid
pair
test
ns
signific
see
also
figur
figur
surprisingli
howev
result
show
activ
protein
translat
requir
stimul
nascent
hcv
rna
synthesi
base
studi
positivestrand
virus
recent
specul
could
promot
hcv
rna
synthesi
form
complex
act
promot
viral
li
et
al
two
molecul
red
font
shown
bound
bait
jopl
et
al
shimakami
et
al
seed
sequencebind
site
highlight
bottom
immunoblot
hnrnp
l
coprecipit
bait
pulldown
experi
pulldown
elimin
preanneal
bait
singlestrand
input
cell
lysat
b
left
mutant
rna
bait
right
immunoblot
hnrnp
l
coprecipit
indic
bait
c
design
experi
assess
impact
deplet
stimul
rna
synthesi
stabli
infect
cell
transfect
twice
control
sirna
sictrl
prior
label
figur
cell
deplet
left
immunoblot
lysat
cell
time
harvest
bactin
load
control
right
quantit
immunoblot
analysi
abund
normal
bactin
cell
sictrltransfect
cell
mean
sem
n
p
mannwhitney
test
e
hcv
rna
abund
lysat
cell
time
harvest
rna
abund
cell
sictrltransfect
cell
two
independ
experi
involv
three
technic
replic
p
mannwhitney
test
f
synthes
follow
mirna
supplement
versu
control
cell
cell
lysat
collect
label
immunoprecipit
antigfp
isotyp
control
ig
antibodi
precipit
separ
sdspage
radiolabel
protein
visual
phosphorimag
g
phosphorimag
quantit
label
nascent
follow
open
bar
shade
bar
supplement
versu
control
cell
label
period
synthesi
significantli
depend
upon
deplet
supplement
p
p
respect
twoway
anova
h
nascent
hcv
rna
synthesi
condit
describ
g
nascent
rna
synthesi
significantli
depend
upon
deplet
mirrdrp
might
facilit
requir
cycliz
genom
prior
negativestrand
rna
synthesi
li
et
al
also
consid
possibl
complex
could
stimul
new
positivestrand
rna
synthesi
bind
end
positivestrand
compon
duplex
replic
intermedi
therebi
promot
strand
separ
free
end
negativestrand
rna
serv
templat
new
positivestrand
rna
synthesi
li
et
al
remain
possibl
none
hypothes
account
activ
protein
translat
requir
stimul
rna
synthesi
altern
hypothesi
could
explain
inabl
stimul
viral
rna
synthesi
follow
shutdown
cellular
translat
suggest
need
regul
engag
viral
rna
translat
versu
rna
synthesi
positivestrand
rna
viru
replic
sinc
genom
virus
serv
templat
translat
rna
synthesi
conflict
inher
movement
translat
ribosom
transloc
rdrp
negativestrand
synthesi
gamarnik
andino
case
polioviru
translat
domin
viral
proteas
becom
suffici
abund
cleav
bind
end
polioviru
rna
intact
form
promot
iresdirect
translat
perera
et
al
hcv
regul
engag
genom
translat
versu
rna
synthesi
known
unlik
util
onoff
switch
due
need
maintain
continu
lowlevel
replic
persist
infect
hepatocyt
puromycin
act
releas
translat
ribosom
messeng
rna
therebi
termin
translat
similar
previou
vitro
studi
polioviru
replic
barton
et
al
puromycininduc
releas
ribosom
hcv
rna
correl
short
term
increas
viral
rna
synthesi
figur
effect
puromycin
induc
artifici
switch
translat
replic
appear
act
fashion
similar
puromycin
facilit
shift
balanc
hcv
genom
engag
translat
versu
rna
synthesi
polysom
analysi
figur
show
increas
viral
rna
synthesi
associ
reproduc
shift
viral
rna
polysom
monosom
fraction
explain
effect
rna
synthesi
presenc
puromycin
ribosom
releas
rna
follow
chx
treatment
frozen
place
effect
partial
substanti
hcv
rna
remain
bound
polysom
continu
translat
presenc
li
et
al
howev
increas
fraction
rna
genom
avail
templat
new
rna
synthesi
seem
like
accomplish
least
part
displac
viral
rna
figur
li
et
al
may
reduc
cycliz
state
viral
rna
wang
et
al
potenti
free
utr
sequenc
interact
replicas
addit
mechan
may
also
involv
includ
chang
tertiari
structur
viral
ire
mortim
doudna
complex
recruit
hcv
rna
could
also
function
reduc
translat
mirnainduc
silenc
complex
normal
effort
requir
answer
question
learn
whether
promot
negativestrand
positivestrand
viral
rna
synthesi
howev
data
present
reveal
mechan
mirna
regul
replic
positivestrand
viru
modul
bind
cellular
protein
viral
rna
control
balanc
engag
rna
protein
translat
versu
viral
rna
synthesi
cell
maintain
describ
jangra
et
al
shimakami
et
al
cmethylcytidin
stuyver
et
al
sof
monophosph
murakami
et
al
kindli
provid
angela
lam
pharmasset
princeton
ann
sluder
scynexi
research
triangl
park
final
dilut
contain
dmso
chx
puromycin
sigmaaldrich
st
loui
invivogen
san
diego
respect
hcv
infect
initi
electropor
cell
rna
transcrib
vitro
molecular
clone
control
replicationdefect
variant
yi
et
al
contain
infram
insert
gaussia
princep
luciferas
gluc
sequenc
shimakami
et
al
yfp
relat
plasmid
enhanc
yfp
sequenc
insert
infram
within
proteincod
sequenc
et
al
vitro
transcrib
rna
electropor
cell
describ
cell
cultur
cell
posit
core
antigen
express
immunofluoresc
assay
yfpexpress
cell
sort
flow
cytometri
nearli
cell
stabli
yfp
posit
matur
mirna
duplex
gener
anneal
equimolar
amount
guid
passeng
strand
alway
transfect
duplex
antirandom
transfect
singlestrand
oligonucleotid
sourc
sequenc
oligonucleotid
describ
supplement
experiment
procedur
vitro
rna
transcript
transfect
rna
transcript
synthes
vitro
describ
shimakami
et
al
transfect
mg
rna
mix
cell
cuvett
puls
v
mf
u
gene
pulser
xcell
total
system
biorad
hercul
mirna
duplex
nm
singlestrand
oligonucleotid
nm
sirna
nm
transfect
cell
use
lipofectamin
rnaimax
life
technolog
carlsbad
accord
manufactur
recommend
procedur
immunoblot
carri
use
standard
method
primari
irdyeconjug
secondari
antibodi
describ
supplement
experiment
procedur
protein
band
visual
quantifi
densitometri
odyssey
infrar
imag
system
licor
bioscienc
lincoln
biotinconjug
rna
repres
nt
hcv
genom
chemic
synthes
use
pulldown
experi
hepatoma
cell
lysat
describ
previous
li
et
al
quantif
coimmunoprecipit
cell
lyse
buffer
contain
mm
trishcl
ph
mm
kcl
mm
edta
triton
mm
dithiothreitol
proteas
inhibitor
cocktail
roch
uml
rnaseout
life
technolog
lysat
preclear
ml
protein
g
sepharos
bead
ge
healthcar
hr
g
sepharos
bead
hr
sepharos
bead
wash
six
time
lysi
buffer
total
rna
extract
use
mircuri
rna
isol
kit
exiqon
quantifi
use
mircuri
lna
univers
rt
microrna
pcr
system
lna
pcr
primer
set
exiqon
metabol
label
measur
nascent
hcv
rna
protein
synthesi
nascent
rna
transcript
quantifi
use
clickit
nascent
rna
captur
kit
life
technolog
modif
manufactur
protocol
cell
puls
mm
hr
mm
hr
mm
hr
incorpor
newli
synthes
rna
cell
wash
pb
total
rna
extract
use
rneasi
mini
kit
qiagen
venlo
total
rna
mg
mm
biotin
azid
use
coppercatalyz
click
reaction
conjug
biotin
rna
follow
precipit
rna
dissolv
ml
rnasefre
water
biotinconjug
isol
mg
total
rna
streptavidin
magnet
bead
use
templat
revers
transcript
cdna
synthesi
prime
primer
use
superscript
iii
firststrand
synthesi
system
life
technolog
follow
taqman
qpcr
analysi
use
iq
supermix
biorad
see
supplement
experiment
procedur
addit
detail
nascent
hcv
rna
abund
normal
total
rna
mg
use
captur
nascent
rna
transcript
streptavidin
magnet
bead
express
copiesmg
total
rna
label
cell
cultur
methionineand
cysteinedefici
dmem
life
technolog
hr
prior
addit
mciwel
express
protein
label
mix
perkinelm
waltham
incub
hr
cell
wash
pb
lyse
mlwell
lysi
buffer
mm
trishcl
ph
contain
mm
nacl
triton
sd
glycerol
supplement
mm
naf
mm
na
vo
complet
proteas
inhibitor
cocktail
roch
mannheim
cell
disrupt
passag
needl
protein
concentr
determin
bradford
protein
assay
biorad
lysat
mg
total
protein
preclear
ml
protein
g
agaros
bead
life
technolog
hr
c
incub
rabbit
antigfp
isotyp
control
overnight
c
protein
g
agaros
bead
ml
ad
lysat
incub
hr
c
wash
five
time
ml
lysi
buffer
boil
min
ml
sd
sampl
buffer
protein
resolv
sdspage
visual
quantifi
phosphorimag
imagequ
softwar
ge
healthcar
fairfield
assess
total
protein
synthesi
radiolabel
cell
lysat
subject
sdspage
without
immunoprecipit
protein
directli
visual
sypro
rubi
protein
gel
stain
biorad
polysom
profil
yfp
infect
cell
dish
treat
puromycin
mgml
hr
transfect
mirna
incub
hr
cell
incub
chx
mgml
min
wash
pb
contain
chx
mgml
mechan
harvest
cell
pellet
lowspe
centrifug
resuspend
ml
polysom
lysi
buffer
plb
mm
kcl
mm
mgcl
mm
trishcl
ph
triton
mm
dtt
mgml
chx
place
ice
min
prior
passag
needl
five
time
centrifug
g
result
supernat
clarifi
centrifug
g
separ
linear
sucros
gradient
prepar
plb
centrifug
ti
rotor
beckman
brea
hr
rpm
c
brake
total
fraction
collect
gradient
continu
monitor
absorb
isco
lincoln
rna
extract
fraction
use
trizol
reagent
life
technolog
subject
cdna
synthesi
random
primer
follow
qpcr
quantit
hcv
bactin
cdna
primer
sequenc
provid
supplement
experiment
procedur
statist
comparison
carri
twotail
mannwhitney
test
unless
otherwis
note
calcul
made
prism
mac
os
x
softwar
graphpad
softwar
la
jolla
p
consid
signific
procedur
found
articl
onlin
http
